# FDA Inspection 1030363 - Halo Pharmaceutical Canada Inc - September 15, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-canada-inc/247fa11a-157e-4df6-b360-a8c14347a7b2
Source feed: FDA_Inspections

> FDA Inspection 1030363 for Halo Pharmaceutical Canada Inc on September 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030363
- Company Name: Halo Pharmaceutical Canada Inc
- Inspection Date: 2017-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1202435 - 2023-02-17](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-canada-inc/73c6b864-e4fa-40b3-8ca1-70148c81355a)
- [FDA Inspection 1202435 - 2023-02-17](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-canada-inc/83b08bd6-ccdb-4e5e-84fb-2815e66f2dab)
- [FDA Inspection 949035 - 2015-11-05](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-canada-inc/a32fcac1-be17-4515-8c3c-8c5ef9ffaa02)
- [FDA Inspection 903523 - 2014-11-14](https://www.globalkeysolutions.net/records/fda_inspections/halo-pharmaceutical-canada-inc/9a34d59f-7cd6-4156-a7b1-2487e109b621)

Company: https://www.globalkeysolutions.net/companies/halo-pharmaceutical-canada-inc/1f4cfadf-e895-4fd7-a813-959f505dd7ce

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c